News | February 24, 2022
Industry needs to ensure quality standards : S Aparna, Union Pharma Secretary
Collaboration in the industry needs to be institutionalised to drive the growth.
Collaboration in the industry needs to be institutionalised to drive the growth.
Four additional AT2R agonists are expected to finalize preclinical evaluation during 2022
Therapeutic use of the product is for short term symptomatic relief of colds, chills and influenza including chesty coughs
9T Labs provides a cost-competitive solution for manufacturing that will allow structural CFRP parts to replace metals at a much faster rate in demanding applications in many sectors such as aerospace, automotive and healthcare
Essential products manufactured by Sartorius, using Sü dpack polymer films made from Dow resins, support safe and effective vaccine production for global vaccine supply
It is India’s 1st indigenously developed Receptor Binding Domain Protein sub-unit vaccine against Covid-19
Covaxin is a whole-virion inactivated Covid-19 investigational vaccine candidate that uses the same vero cell manufacturing platform that has been used in the production of polio vaccines for decades
The focus should be on streamlining regulations, developing new molecules, increased industry academia collaboration and tapping the potential of traditional medicines
Launching Dexamethasone, Azacitidine, Carboprost, and Atropine for the Institutional Market
The partnership will help digitize and automate existing tasks traditionally managed on paper, significantly reducing costs and lead times while increasing compliance
Subscribe To Our Newsletter & Stay Updated
